Home/Companies/Biotech/Booster Therapeutics

Booster Therapeutics

Biotech·

Germany·Active·2yr hold

Entry

2024

Hold

2yr

Status

Active

Who owns Booster Therapeutics?

Booster Therapeutics is a German Biotech company, currently owned by Novo Holdings since 2024 and Apollo Health Ventures.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY

Most recent investor

Apollo Health Ventures

Apollo Health Ventures Fund II · 2021 · Life Sciences VC

2 ownership periods · full history below

Key facts

HQGermany

SectorBiotech

StatusActive

Ownership history

2 ownership periods · co-invest detected

Active

Co-held by Novo Holdings and Apollo Health Ventures since 2024.

Co-invest · 2 holders · 2024 · present

Novo HoldingsActive

2024 · present(2yr) · Novo Holdings Seed Investments · 1999 · VC

Apollo Health VenturesActive

2024 · present(2yr) · Apollo Health Ventures Fund II · 2021 · Life Sciences VC

More from Apollo Health Ventures Fund II

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns Booster Therapeutics?

Booster Therapeutics is currently owned by Novo Holdings and Apollo Health Ventures, through Apollo Health Ventures Fund II, since 2024.

When did Novo Holdings and 1 other acquire Booster Therapeutics?

Novo Holdings and 1 other acquired Booster Therapeutics in 2024.

Who has owned Booster Therapeutics over time?

Booster Therapeutics has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2024; Apollo Health Ventures · via Apollo Health Ventures Fund II · since 2024.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue